60 Degrees Pharmaceuticals (SXTP) Competitors $0.96 -0.02 (-1.84%) (As of 01:41 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends SXTP vs. CYCN, APM, GTBP, ABVC, ADIL, ENSC, HOTH, AEZS, ERNA, and TFFPShould you be buying 60 Degrees Pharmaceuticals stock or one of its competitors? The main competitors of 60 Degrees Pharmaceuticals include Cyclerion Therapeutics (CYCN), Aptorum Group (APM), GT Biopharma (GTBP), ABVC BioPharma (ABVC), Adial Pharmaceuticals (ADIL), Ensysce Biosciences (ENSC), Hoth Therapeutics (HOTH), Aeterna Zentaris (AEZS), Eterna Therapeutics (ERNA), and TFF Pharmaceuticals (TFFP). These companies are all part of the "pharmaceutical preparations" industry. 60 Degrees Pharmaceuticals vs. Cyclerion Therapeutics Aptorum Group GT Biopharma ABVC BioPharma Adial Pharmaceuticals Ensysce Biosciences Hoth Therapeutics Aeterna Zentaris Eterna Therapeutics TFF Pharmaceuticals 60 Degrees Pharmaceuticals (NASDAQ:SXTP) and Cyclerion Therapeutics (NASDAQ:CYCN) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, media sentiment, institutional ownership, profitability, analyst recommendations, community ranking, valuation and dividends. Which has preferable valuation and earnings, SXTP or CYCN? 60 Degrees Pharmaceuticals has higher earnings, but lower revenue than Cyclerion Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio60 Degrees Pharmaceuticals$250K7.29-$3.77M$0.0910.68Cyclerion Therapeutics$1.62M3.06-$5.26MN/AN/A Is SXTP or CYCN more profitable? 60 Degrees Pharmaceuticals' return on equity of 0.00% beat Cyclerion Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets 60 Degrees PharmaceuticalsN/A N/A -98.31% Cyclerion Therapeutics N/A -66.84%-57.28% Which has more risk & volatility, SXTP or CYCN? 60 Degrees Pharmaceuticals has a beta of 4.78, suggesting that its share price is 378% more volatile than the S&P 500. Comparatively, Cyclerion Therapeutics has a beta of 1.93, suggesting that its share price is 93% more volatile than the S&P 500. Does the MarketBeat Community prefer SXTP or CYCN? Cyclerion Therapeutics received 33 more outperform votes than 60 Degrees Pharmaceuticals when rated by MarketBeat users. Likewise, 58.62% of users gave Cyclerion Therapeutics an outperform vote while only 16.67% of users gave 60 Degrees Pharmaceuticals an outperform vote. CompanyUnderperformOutperform60 Degrees PharmaceuticalsOutperform Votes116.67%Underperform Votes583.33% Cyclerion TherapeuticsOutperform Votes3458.62% Underperform Votes2441.38% Does the media prefer SXTP or CYCN? In the previous week, 60 Degrees Pharmaceuticals had 1 more articles in the media than Cyclerion Therapeutics. MarketBeat recorded 3 mentions for 60 Degrees Pharmaceuticals and 2 mentions for Cyclerion Therapeutics. 60 Degrees Pharmaceuticals' average media sentiment score of 0.59 beat Cyclerion Therapeutics' score of 0.43 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment 60 Degrees Pharmaceuticals Positive Cyclerion Therapeutics Neutral Do analysts rate SXTP or CYCN? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 60 Degrees Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Cyclerion Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders & institutionals believe in SXTP or CYCN? 8.0% of 60 Degrees Pharmaceuticals shares are owned by institutional investors. Comparatively, 75.6% of Cyclerion Therapeutics shares are owned by institutional investors. 10.3% of 60 Degrees Pharmaceuticals shares are owned by insiders. Comparatively, 36.1% of Cyclerion Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Summary60 Degrees Pharmaceuticals beats Cyclerion Therapeutics on 7 of the 13 factors compared between the two stocks. Ad Porter & CompanyElon Musk has put himself in their crosshairsToday, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.I share with you in this special investigative documentary. Get 60 Degrees Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SXTP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SXTP vs. The Competition Export to ExcelMetric60 Degrees PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.82M$6.77B$5.24B$8.94BDividend YieldN/A8.07%4.98%4.03%P/E Ratio10.688.49114.3216.31Price / Sales7.29399.801,295.1492.28Price / CashN/A49.2239.1636.42Price / Book-0.099.296.425.98Net Income-$3.77M$154.14M$118.63M$225.08M7 Day Performance-8.41%-3.64%-0.91%0.03%1 Month Performance2.08%5.81%3.49%4.55%1 Year Performance50.47%38.55%36.94%27.70% 60 Degrees Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SXTP60 Degrees Pharmaceuticals1.9729 of 5 stars$0.96-1.8%N/A+64.2%$1.79M$250,000.0010.493Upcoming EarningsShort Interest ↑News CoverageGap DownCYCNCyclerion Therapeutics1.3151 of 5 stars$2.53+2.4%N/A-16.8%$7.05M$1.62M0.0030Short Interest ↑Gap UpAPMAptorum Group0.7913 of 5 stars$1.23-3.9%N/A-24.1%$6.89M$430,000.000.0030Short Interest ↑GTBPGT Biopharma0.6027 of 5 stars$3.33+7.4%N/A-54.5%$6.68MN/A0.008Short Interest ↑Gap UpHigh Trading VolumeABVCABVC BioPharma0.5919 of 5 stars$0.53-3.7%N/A-53.1%$6.54M$150,000.00-0.3230Upcoming EarningsShort Interest ↑News CoverageGap UpADILAdial Pharmaceuticals2.6876 of 5 stars$1.04-2.8%N/A-50.7%$6.47MN/A0.0020Analyst ForecastShort Interest ↑News CoverageENSCEnsysce Biosciences0.4483 of 5 stars$0.73+4.3%N/A-14.8%$6.44M$2.23M-0.2610Earnings ReportShort Interest ↑News CoverageGap UpHOTHHoth Therapeutics2.9863 of 5 stars$0.92+2.2%N/A-24.7%$6.33MN/A-0.574Short Interest ↑AEZSAeterna ZentarisN/A$3.35-3.2%N/A-49.3%$6.01M$2.37M-0.2320ERNAEterna Therapeutics1.0408 of 5 stars$1.10+1.9%N/A-14.2%$5.94M$70,000.00-0.2510Short Interest ↓News CoverageTFFPTFF Pharmaceuticals2.3846 of 5 stars$1.68+3.1%N/A-69.5%$5.83M$730,000.00-0.2119Short Interest ↑ Related Companies and Tools Related Companies CYCN Competitors APM Competitors GTBP Competitors ABVC Competitors ADIL Competitors ENSC Competitors HOTH Competitors AEZS Competitors ERNA Competitors TFFP Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SXTP) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredElon Musk has put himself in their crosshairsToday, I have another controversial prediction. One which I will take no pleasure in seeing come true. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 60 Degrees Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 60 Degrees Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SXTP Stock Alerts